Ophthalmic Suspension (neomycin and polymyxin B sulfates and hydrocortisone) is a combination of two antibiotics and a steroid used to treat bacterial infections of the eyes. Ophthalmic Suspension is available in generic form.
Increasing prevalence of eye diseases across the globe is one of the major factors contributing to the growth of this market. Moreover, increasing geriatric population which are most prone to eye disorders, and growing number of bacterial infections cases in children will also boost the growth of the market. Furthermore, according to WHO (2014), glaucoma is the second major cause of blindness in the world which will increase the market growth.
In 2019, the market size of Ophthalmic Suspension is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ophthalmic Suspension.
This report studies the global market size of Ophthalmic Suspension, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Ophthalmic Suspension sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Allergan
Merck
Novartis
Bausch & Lomb
Falcon Group
Pfizer
Valeant
Market Segment by Product Type
Antibiotic
Antifungal
Antibacterial
Steroids
NSAIDs
Market Segment by Application
Bacterial Infections
Retinal Disorders
Glaucoma
Allergies
Diabetic Eye Disease
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)